Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Cancer J. 2012 Jan;18(1):45–50. doi: 10.1097/PPO.0b013e3182431c6f

Table 2.

Possible toxicities of antiangiogenic agents

Toxicity Possible Mechanism
Hypertension blockade of NO and prostacyclins, decreased capillary density, impaired baroreceptor response, kidney damage
Thrombotic events EC apoptosis, platelet activation
Bleeding, Impaired wound healing platelet dysfunction
Proteinuria podocyte dysfunction in kidney glomeruli
Hand-foot syndrome epidermal cell apoptosis, EC dysfunction
GI perforation mucosal cell apoptosis, EC dysfunction
Hypothyroidism decreased thyroid vascularity
Fatigue hypothyroidism- unclear
PRES BBB dysregulation, hypertension

EC- endothelial cell; NO- nitric oxide; GI- gastrointestinal; PRES- posterior reversible encephalopathy syndrome